Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.47 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.47 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.47 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.47 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.47 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.47 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.47 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | KIF11 | P52732 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8881303 | 0.90 | TRPV1 (0.46) | TSHRCYP1A2LMNATYRGRIN2D | |
| SCHEMBL18240646 | 0.88 | MEN1 (0.48) | TSHRCYP1A2LMNATYRGRIN2D | |
| SCHEMBL1825727 | 0.82 | CYP1A2 (0.64) | TSHRCYP1A2LMNATYRGRIN2D | |
| SCHEMBL1825729 | 0.82 | CYP1A2 (0.64) | TSHRCYP1A2LMNATYRGRIN2D | |
| SCHEMBL424728 | 0.80 | TSHR (0.73) | TSHRCYP1A2LMNATYRKIF11 | |
| SCHEMBL14205332 | 0.80 | GRIN2D (0.50) | TSHRCYP1A2LMNATYRGRIN2D | |
| SCHEMBL141087 | 0.80 | CYP1A2 (0.50) | TSHRCYP1A2LMNATYRGRIN2D | |
| SCHEMBL29145894 | 0.80 | CYP1A2 (0.61) | TSHRCYP1A2LMNATYRGRIN2D | |
| SCHEMBL43060 | 0.78 | EPHX2 (0.56) | TSHRCYP1A2LMNATYRGRIN2D | |
| SCHEMBL9454070 | 0.78 | CYP1A2 (0.48) | TSHRCYP1A2LMNATYRGRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118176220-A | Catalyst for olefin polymerization and process for producing olefin polymer | 国立大学法人东京大学 | 2024-06-11 | — | — | CN | disclosed |
| EP-2419391-B1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | CANON KK (JP) | 2014-04-30 | — | — | EP | disclosed |
| EP-2417085-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | Canon Kabushiki Kaisha (JP) | 2012-02-15 | — | — | EP | disclosed |
| US-20120013700-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2012-01-19 | — | — | US | disclosed |
| US-20110315973-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2011-12-29 | — | — | US | disclosed |
| WO-2010116661-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2010-10-14 | — | — | WO | disclosed |
| US-20070189058-A1 | Molecular system and method for reversibly switching the same between four states | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2007-08-16 | — | — | US | disclosed |
| US-20070112103-A1 | Molecular system and method for reversibly switching the same | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2007-05-17 | — | — | US | disclosed |
| CN-1782044-A | Synthetic lubricating oil and lubricating oil composition | MITSUI CHEMICALS INC (JP) | 2006-06-07 | — | — | CN | disclosed |
| US-6358665-B1 | ONIUM SALT PRECURSOR FOR GENERATING FLUOROALKYLSULFONATE | CLARIANT INTERNATIONAL LTD. (CH) | 2002-03-19 | — | — | US | disclosed |
| EP-1033624-A1 | RADIATION-SENSITIVE COMPOSITION OF CHEMICAL AMPLIFICATION TYPE | Clariant International Ltd. (CH) | 2000-09-06 | — | — | EP | disclosed |
| US-5622953-A | DRUG RESISTANT TO ANTICANCER CHEMOTHERAPEUTIC DRUG | BASF AKTIENGESELLSCHAFT (DE) | 1997-04-22 | — | — | US | disclosed |
| EP-0691962-A1 | 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE | BASF AKTIENGESELLSCHAFT (DE) | 1996-01-17 | — | — | EP | disclosed |
| WO-1994022842-A1 | 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE | BASF AKTIENGESELLSCHAFT (DE) | 1994-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110315973-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | NR2E3, PYM1, TYR | TSHR 2717/4885CYP1A2 151/4885LMNA 2850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.